Constitutive expression of Bcl-2 induces epithelial-Mesenchymal transition in mammary epithelial cells

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  An, Juan ^a   Lv, Jin ^a   Li, Aimin ^a   Qiao, Junxiao ^a   Fang, Liang ^a   Li, Zhihua ^a   Li, Bo ^a   Zhao, Wei ^a   Chen, Huoming ^a   Wang, Liying ^a  

^a Second Artillery   (China)

Author keywords

Bcl2; Differentiation; Epithelial; Mesenchymal

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; EPITHELIAL SPECIFIC ANTIGEN; PROTEIN BCL 2; TUMOR ANTIGEN; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; VIMENTIN;

APOPTOSIS; ARTICLE; BREAST EPITHELIUM CELL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MORPHOGENESIS; PATHOGENESIS; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING; BIOSYNTHESIS; BREAST TUMOR; CELL DIFFERENTIATION; CELL MOTION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MAMMARY GLAND; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CADHERINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, HUMAN; PROTO-ONCOGENE PROTEINS C-BCL-2; VIMENTIN;

EID: 84934949710     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1485-5     Document Type: Article

References (26)

1. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol. 2003;39:615-47.
2. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR. The BCL-2 family reunion. Mol Cell. 2010;37:299-310.
3. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002;2:647-56.
4. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442-54.
5. Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays. 2001;23:912-23.
6. Boyer B, Valles AM, Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol. 2000;60:1091-9.
7. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat (Basel). 1995;154:8-20.
8. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR. MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol. 1996;148:313-9.
9. Upadhyay S, Li G, Liu H, Chen YQ, Sarkar FH, Kim HR. bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells. Cancer Res. 1995;55:4520-4.
10. van Londen G, Beckjord E, Dew M, Cuijpers P, Tadic S, Brufsky A. Breast cancer survivorship symptom management: current perspective and future development. Breast Cancer Manag. 2013;2:71-81.
11. Moran TJ, Gray S, Mikosz CA, Conzen SD. The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. Cancer Res. 2000;60:867-72.
12. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 2000;148:779-90.
13. Vleminckx K, Kemler R. Cadherins and tissue formation: integrating adhesion and signaling. Bioessays. 1999;21:211-20.
14. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76-83.
15. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001;7:1267-78.
16. Yang MH, Wu KJ. TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle. 2008;7:2090-6.
17. Sun T, Sun BC, Zhao XL, Zhao N, Dong XY, Che N, et al. Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma. Hepatology. 2011;54:1690-706.
18. Xie L, Qin W, Li J, He X, Zhang H, Yao G, et al. BNIPL-2 promotes the invasion and metastasis of human hepatocellular carcinoma cells. Oncol Rep. 2007;17:605-10.
19. Planas-Silva MD, Bruggeman RD, Grenko RT, Smith JS. Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer. Exp Mol Pathol. 2007;82:85-90.
20. Mena S, Benlloch M, Ortega A, Carretero J, Obrador E, Asensi M, et al. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease. Clin Cancer Res. 2007;13:2658-66.
21. Pinkas J, Martin SS, Leder P. Bcl-2-mediated cell survival promotes metastasis of EpH4 betaMEKDD mammary epithelial cells. Mol Cancer Res. 2004;2:551-6.
22. Zuo J, Ishikawa T, Boutros S, Xiao Z, Humtsoe JO, Kramer RH. Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis. Mol Cancer Res. 2010;8:170-82.
23. Lu PJ, Lu QL, Rughetti A, Taylor-Papadimitriou J. bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J Cell Biol. 1995;129:1363-78.
24. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer. 2005;5:744-9.
25. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE. 2008;3:e2888.
26. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704-15.